Fig. 1
From: Economic Costs of Myasthenia Gravis: A Systematic Review
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) diagram of the selection process of the included publications. MG Myasthenia gravis
Fig. 1 | PharmacoEconomics